| Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance N Anreddy, P Gupta, RJ Kathawala, A Patel, JND Wurpel, ZS Chen Molecules 19 (9), 13848-13877, 2014 | 117 | 2014 |
| In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1 H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, ... British journal of pharmacology 171 (24), 5845-5857, 2014 | 65 | 2014 |
| Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo K Sodani, A Patel, N Anreddy, S Singh, DH Yang, RJ Kathawala, P Kumar, ... Biochemical pharmacology 89 (1), 52-61, 2014 | 58 | 2014 |
| PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells A Patel, AK Tiwari, EE Chufan, K Sodani, N Anreddy, S Singh, ... Cancer chemotherapy and pharmacology 72, 189-199, 2013 | 58 | 2013 |
| Masitinib antagonizes ATP-binding cassette subfamily C member 10–mediated Paclitaxel resistance: a preclinical study RJ Kathawala, K Sodani, K Chen, A Patel, AH Abuznait, N Anreddy, ... Molecular cancer therapeutics 13 (3), 714-723, 2014 | 44 | 2014 |
| Exploring naturally occurring ivy nanoparticles as an alternative biomaterial Y Huang, YJ Wang, Y Wang, S Yi, Z Fan, L Sun, D Lin, N Anreddy, H Zhu, ... Acta biomaterialia 25, 268-283, 2015 | 43 | 2015 |
| A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo N Anreddy, A Patel, YK Zhang, YJ Wang, S Shukla, RJ Kathawala, ... Oncotarget 6 (36), 39276, 2015 | 34 | 2015 |
| The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study RJ Kathawala, L Wei, N Anreddy, K Chen, A Patel, S Alqahtani, YK Zhang, ... Oncotarget 6 (1), 510, 2015 | 34 | 2015 |
| PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR N Anreddy, A Patel, K Sodani, RJ Kathawala, EP Chen, JND Wurpel, ... Acta Pharmaceutica Sinica B 4 (3), 202-207, 2014 | 34 | 2014 |
| Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin YJ Wang, Y Huang, N Anreddy, GN Zhang, YK Zhang, M Xie, D Lin, ... Oncotarget 7 (5), 5877, 2016 | 33 | 2016 |
| Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies J Li, P Kumar, N Anreddy, YK Zhang, YJ Wang, Y Chen, TT Talele, ... Oncotarget 8 (55), 93785, 2017 | 23 | 2017 |
| MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma MF Emmons, N Anreddy, J Cuevas, K Steinberger, S Yang, M McLaughlin, ... Scientific reports 7 (1), 2685, 2017 | 18 | 2017 |
| Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport A Patel, TW Li, N Anreddy, DS Wang, K Sodani, S Gadhia, R Kathawala, ... Pharmacological research 121, 184-193, 2017 | 17 | 2017 |
| Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1 YJ Wang, BA Patel, N Anreddy, YK Zhang, GN Zhang, S Alqahtani, ... Scientific reports 7 (1), 42106, 2017 | 14 | 2017 |
| Targeting intrinsic and extrinsic vulnerabilities for the treatment of multiple myeloma N Anreddy, LA Hazlehurst Journal of cellular biochemistry 118 (1), 15-25, 2017 | 12 | 2017 |
| P-gp inhibitory activity from marine sponges, tunicates and algae X Huang, P Kumar, N Anreddy, X Xiao, DH Yang, ZS Chen Handbook of Anticancer Drugs from Marine Origin, 593-619, 2015 | 3 | 2015 |
| TTT-28, a newly synthesized thiazole-valine peptide, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1 transporter YJ Wang, N Anreddy, BA Patel, EE Chufan, S Singh, GN Zhang, ... Cancer Research 75 (15_Supplement), 4422-4422, 2015 | | 2015 |
| Design, synthesis and biological evaluation of N-aryl-3, 3, 3-trifluoro-2-hydroxy-2-methylpropionamide analog as a promising inhibitor of the multidrug resistance-linked ABCG2 … AS Patel, T Li, N Anreddy, Y Zhao, RJ Kathawala, Y Wang, SV Ambudkar, ... Cancer Research 75 (15_Supplement), 4419-4419, 2015 | | 2015 |
| Abstract A01: A-803467, a sodium channel blocker, reverses ABCG2-mediated MDR in vitro as well as in vivo N Anreddy, P Kumar, A Patel, YK Zhang, Y Wang, R Kathawala, ... Clinical Cancer Research 21 (4_Supplement), A01-A01, 2015 | | 2015 |
| A-803467 circumvents ABCG2-mediated multi drug resistance in vitro and in vivo N Anreddy St. John's University (New York), 2015 | | 2015 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's University在 stjohns.edu 的电子邮件经过验证
